希少疾患用医療食品の世界市場レポート 2025年

希少疾患用医療食品の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.4％で18億米ドルに成長します。予測期間の成長は、遠隔医療と遠隔モニタリング、ヘルスケアシステムの統合、食品科学における新技術、精密栄養、患者需要の増加に起因します。予測期間の主な動向には、長期有効性研究、疾患特異的製剤、教育訓練プログラム、腸内マイクロバイオームへの注目、栄養補助食品の革新などがあります。

今後5年間の成長率6.4%という予測は、この市場に関する前回の予測から変更はありません。しかしながら、米国と他国との間の関税の影響により、オランダからの希少な栄養製剤のコストを上昇させ、クリティカルケアへのアクセスを制限することで、米国に直接影響を及ぼす可能性があります。また、相互関税や、貿易の緊張と制限の高まりによる世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

希少疾患用医療食品市場の成長が予想される背景には、希少疾病とも呼ばれる、集団の中で比較的少数の患者が罹患する希少疾病の発生率の増加があります。こうした病状には専門的な栄養介入が必要であり、医療食品は希少疾病患者の特定の食事要件を満たす上で重要な役割を果たしています。非ホジキンリンパ腫や特発性肺線維症などの希少疾病の有病率の上昇は、希少疾患用医療食品市場の拡大に寄与しています。例えば、2023年1月、米国がん協会は、非ホジキンリンパ腫が米国におけるがん患者の約4％を占め、2023年には8万550人が新たに診断されると推定されると報告しました。さらに、2022年9月に発表された調査研究では、特発性肺線維症の有病率の増加が明らかになり、2021年には人口10万人当たり36症例に達しました。このように、希少疾病の発生率の増加が希少疾患用医療食品市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の希少疾患用医療食品：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の希少疾患用医療食品市場：成長率分析
• 世界の希少疾患用医療食品市場の実績：規模と成長、2019～2024年
• 世界の希少疾患用医療食品市場の予測：規模と成長、2024～2029年、2034年
• 世界の希少疾患用医療食品：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の希少疾患用医療食品市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 丸薬
• 粉末
• 液体
• その他
• 世界の希少疾患用医療食品市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 経腸
• 世界の希少疾患用医療食品市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• フェニルケトン尿症
• チロシン血症
• 好酸球性食道炎
• 食物タンパク質誘発性腸炎症候群（FPIES）
• メープルシロップ尿症（MSUD）
• ホモシスチン尿症
• その他
• 世界の希少疾患用医療食品市場：販売チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• オンライン販売
• 業務向け販売
• 小売販売
• 世界の希少疾患用医療食品市場：丸薬のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• 世界の希少疾患用医療食品市場：粉末のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プロテインパウダー
• 栄養補助食品
• 世界の希少疾患用医療食品市場：液体のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• そのまま飲めるフォーミュラ
• 液体栄養補助食品
• 世界の希少疾患用医療食品市場：その他のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 栄養バー
• 強化食品
• すぐに使える医療食品

第7章 地域別・国別分析

• 世界の希少疾患用医療食品市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の希少疾患用医療食品市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 希少疾患用医療食品市場：競合情勢
• 希少疾患用医療食品市場：企業プロファイル
  • Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Ajinomoto Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Meiji Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Fresenius Kabi AG
• BioMarin Pharmaceutical Inc.
• Halyard Health
• Alfasigma spA
• Ultragenyx Pharmaceutical Inc.
• Immedica Group AB
• Vitaflo International Ltd.
• Leadiant Biosciences Inc.
• Alcresta Therapeutics Inc.
• Cambrooke Therapeutics Inc.
• Primus Pharmaceuticals Inc.
• CANbridge Pharmaceuticals Inc.
• Cerecin Inc.
• AMNIOX Medical Inc.
• Targeted Medical Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 希少疾患用医療食品市場2029年：新たな機会を提供する国
• 希少疾患用医療食品市場2029年：新たな機会を提供するセグメント
• 希少疾患用医療食品市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Specialized nutritional products tailored for orphan diseases encompass medical foods designed to address the distinct dietary requirements of individuals affected by rare, genetic, or orphan diseases. These products, available in pill, powder, liquid, and other forms, serve as targeted solutions for patients dealing with rare orphan diseases.

Medical food pills represent specific oral formulations crafted to deliver precise nutrients, dietary components, or therapeutic agents in a convenient pill format. These pills aim to meet unique nutritional needs and tackle metabolic imbalances associated with orphan diseases. Administered orally and through enteral routes, these medical foods play a crucial role in the treatment of conditions such as phenylketonuria, tyrosinemia, eosinophilic esophagitis, food protein-induced enterocolitis syndrome (FPIES), maple syrup urine disease (MSUD), homocystinuria, and others. These specialized products are available for purchase online, through institutes, and in retail stores, catering to the needs of individuals grappling with orphan diseases.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid implementation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a notable impact on the food and beverage sector. Rising costs for imported ingredients such as olive oil, cheese, and tropical fruits are pressuring food manufacturers to either reformulate their products or absorb reduced profit margins. Beverage producers are similarly affected, with tariffs on aluminum cans driving up packaging costs. Meanwhile, retaliatory tariffs on U.S. agricultural exports like soybeans and pork are disrupting farm-to-processor supply chains. In response, companies are adjusting recipes, increasing local sourcing, and using commodity hedging strategies to manage price volatility.

The medical foods for orphan diseases treatment market research report is one of a series of new reports from The Business Research Company that provides medical foods for orphan diseases treatment market statistics, including the medical foods for orphan diseases treatment industry's global market size, regional shares, competitors with medical foods for orphan diseases treatment market share, detailed medical foods for orphan diseases treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the medical foods for orphan diseases treatment industry. This medical foods for orphan diseases treatment market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical foods for orphan diseases market size has grown strongly in recent years. It will grow from $1.33 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to orphan drug designation, research & development advances, government funding & grants, regulatory frameworks, improved diagnosis.

The medical foods for orphan diseases market size is expected to see strong growth in the next few years. It will grow to " $1.8 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to telemedicine and remote monitoring, healthcare system integration, emerging technologies in food science, precision nutrition, increased patient demand. Major trends in the forecast period include long-term efficacy studies, disease-specific formulations, education and training programs, focus on gut microbiome, nutritional supplements innovation.

The forecast of 6.4% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing costs for rare nutrient formulations from the Netherlands, limiting access for critical care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the medical foods for orphan diseases market is driven by the increasing incidence of orphan diseases, also known as rare diseases, which affect a relatively small number of individuals within a population. These medical conditions necessitate specialized nutritional interventions, and medical foods play a crucial role in meeting the specific dietary requirements of patients with orphan diseases. The rise in the prevalence of orphan diseases, such as non-Hodgkin lymphoma and idiopathic pulmonary fibrosis, contributes to the expansion of the medical foods for orphan diseases market. For example, in January 2023, the American Cancer Society reported that non-Hodgkin lymphoma accounted for approximately 4% of cancer cases in the United States, with an estimated 80,550 new diagnoses in 2023. Additionally, a research study published in September 2022 revealed an increasing prevalence of idiopathic pulmonary fibrosis, reaching 36 cases per 100,000 people in 2021.

The growth of the medical foods for orphan diseases market is also fueled by the increasing incidence of chronic diseases. Chronic diseases, characterized by their long-lasting nature, lasting for three months or more, drive the demand for medical foods to address specific nutritional deficiencies and metabolic imbalances associated with these conditions. The World Health Organization (WHO) reported in September 2023 that chronic diseases contribute significantly to global mortality, with 41 million deaths annually, representing 74% of all fatalities. The specific breakdown includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. This increasing incidence of chronic diseases underscores the growing need for medical foods in managing and improving outcomes for individuals with orphan diseases.

Product innovation is a prominent trend gaining traction in the medical foods for orphan diseases market, with major companies strategically introducing innovative products to solidify their market positions. Notably, in October 2022, Relief Therapeutics, a Switzerland-based biopharmaceutical company, unveiled PKU GOLIKE, a groundbreaking medical food product developed with the company's patented Physiomimic Technology platform. This innovation targets the dietary management of phenylketonuria (PKU), an inherited rare disorder. PKU GOsuch as stands out as the first prolonged-release amino acid product, featuring a specialized coating that ensures the physiological absorption of amino acids while concealing the unpleasant taste, odor, and aftertaste associated with these compounds. The product is classified as a phenylalanine-free food designed for special medical purposes (FSMP) in the United States.

Major players in the medical foods for orphan diseases market are actively involved in the development of PKU GOLIKE, a revolutionary product tailored for managing symptoms of phenylketonuria (PKU). Launched by Relief Therapeutics in October 2022, PKU GOsuch as represents a phenylalanine-free food created for special medical purposes (FSMP). It is the first prolonged-release amino acid supplement, leveraging Relief Therapeutics' patented physiomimic technology platform to ensure physiological amino acid absorption, mimicking the natural protein absorption process.

In July 2023, Pentec Health, a US-based company specializing in innovative medication management solutions for patients with complex medical needs, acquired ZOIA Pharma for an undisclosed amount. This acquisition is intended to enhance Pentec Health's medical food services as a Complex Care Provider, ensuring that ZOIA Pharma customers can access innovative solutions for managing phenylketonuria (PKU) while addressing common patient concerns. ZOIA Pharma is a US-based organization dedicated to developing medical foods specifically for the treatment of orphan diseases.

Major companies operating in the medical foods for orphan diseases market include Nestle S.A., Abbott Laboratories Inc., Danone S.A., Ajinomoto Co. Inc., Meiji Holdings Co. Ltd., Fresenius Kabi AG, BioMarin Pharmaceutical Inc., Halyard Health, Alfasigma spA, Ultragenyx Pharmaceutical Inc., Immedica Group AB, Vitaflo International Ltd., Leadiant Biosciences Inc., Alcresta Therapeutics Inc., Cambrooke Therapeutics Inc., Primus Pharmaceuticals Inc., CANbridge Pharmaceuticals Inc., Cerecin Inc., AMNIOX Medical Inc., Targeted Medical Pharma Inc., Solace Nutrition LLC, Orphan Therapeutics LLC, Metagenics Inc., Farma Genetics Inc.

North America was the largest region in the medical foods for orphan diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical foods for orphan diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical foods for orphan diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical foods for orphan diseases market consist of sales of nutritionally complete formulas and nutritionally incomplete formulas. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Foods For Orphan Diseases Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical foods for orphan diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical foods for orphan diseases ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical foods for orphan diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Pills; Powder; Liquid; Other Products
• 2) By Route Of Administration: Oral; Enteral
• 3) By Applications: Phenylketonuria; Tyrosinemia; Eosinophilic esophagitis; Food Protein-Induced Enterocolitis Syndrome (FPIES); Maple Syrup Urine Disease (MSUD); Homocystinuria; Other Applications
• 4) By Sales Channel: Online Sales; Institutional Sales; Retail Sales
• Subsegments:

1) By Pills; Tablets; Capsules

• 2) By Powder: Protein Powders; Nutritional Supplement Powders
• 3) By Liquid: Ready-To-Drink Formulas; Liquid Nutritional Supplements
• 4) By Other Products: Nutritional Bars; Fortified Foods; Ready-To-Use Therapeutic Foods
• Companies Mentioned: Nestle S.A.; Abbott Laboratories Inc.; Danone S.A.; Ajinomoto Co. Inc.; Meiji Holdings Co. Ltd.; Fresenius Kabi AG; BioMarin Pharmaceutical Inc.; Halyard Health; Alfasigma spA; Ultragenyx Pharmaceutical Inc.; Immedica Group AB; Vitaflo International Ltd.; Leadiant Biosciences Inc.; Alcresta Therapeutics Inc.; Cambrooke Therapeutics Inc.; Primus Pharmaceuticals Inc.; CANbridge Pharmaceuticals Inc.; Cerecin Inc.; AMNIOX Medical Inc.; Targeted Medical Pharma Inc.; Solace Nutrition LLC; Orphan Therapeutics LLC; Metagenics Inc.; Farma Genetics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Italy; Spain; Canada
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Foods For Orphan Diseases Market Characteristics

3. Medical Foods For Orphan Diseases Market Trends And Strategies

4. Medical Foods For Orphan Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Medical Foods For Orphan Diseases Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Foods For Orphan Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Foods For Orphan Diseases Market Growth Rate Analysis
• 5.4. Global Medical Foods For Orphan Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Foods For Orphan Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Foods For Orphan Diseases Total Addressable Market (TAM)

6. Medical Foods For Orphan Diseases Market Segmentation

• 6.1. Global Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pills
• Powder
• Liquid
• Other Products
• 6.2. Global Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Enteral
• 6.3. Global Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenylketonuria
• Tyrosinemia
• Eosinophilic esophagitis
• Food Protein-Induced Enterocolitis Syndrome (FPIES)
• Maple Syrup Urine Disease (MSUD)
• Homocystinuria
• Other Applications
• 6.4. Global Medical Foods For Orphan Diseases Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Sales
• Institutional Sales
• Retail Sales
• 6.5. Global Medical Foods For Orphan Diseases Market, Sub-Segmentation Of Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• 6.6. Global Medical Foods For Orphan Diseases Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Powders
• Nutritional Supplement
• 6.7. Global Medical Foods For Orphan Diseases Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ready-To-Drink Formulas
• Liquid Nutritional Supplements
• 6.8. Global Medical Foods For Orphan Diseases Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nutritional Bars
• Fortified Foods
• Ready-To-Use Therapeutic Foods

7. Medical Foods For Orphan Diseases Market Regional And Country Analysis

• 7.1. Global Medical Foods For Orphan Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Foods For Orphan Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Foods For Orphan Diseases Market

• 8.1. Asia-Pacific Medical Foods For Orphan Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Foods For Orphan Diseases Market

• 9.1. China Medical Foods For Orphan Diseases Market Overview
• 9.2. China Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Foods For Orphan Diseases Market

• 10.1. India Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Foods For Orphan Diseases Market

• 11.1. Japan Medical Foods For Orphan Diseases Market Overview
• 11.2. Japan Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Foods For Orphan Diseases Market

• 12.1. Australia Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Foods For Orphan Diseases Market

• 13.1. Indonesia Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Foods For Orphan Diseases Market

• 14.1. South Korea Medical Foods For Orphan Diseases Market Overview
• 14.2. South Korea Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Foods For Orphan Diseases Market

• 15.1. Western Europe Medical Foods For Orphan Diseases Market Overview
• 15.2. Western Europe Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Foods For Orphan Diseases Market

• 16.1. UK Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Foods For Orphan Diseases Market

• 17.1. Germany Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Foods For Orphan Diseases Market

• 18.1. France Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Foods For Orphan Diseases Market

• 19.1. Italy Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Foods For Orphan Diseases Market

• 20.1. Spain Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Foods For Orphan Diseases Market

• 21.1. Eastern Europe Medical Foods For Orphan Diseases Market Overview
• 21.2. Eastern Europe Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Foods For Orphan Diseases Market

• 22.1. Russia Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Foods For Orphan Diseases Market

• 23.1. North America Medical Foods For Orphan Diseases Market Overview
• 23.2. North America Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Foods For Orphan Diseases Market

• 24.1. USA Medical Foods For Orphan Diseases Market Overview
• 24.2. USA Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Foods For Orphan Diseases Market

• 25.1. Canada Medical Foods For Orphan Diseases Market Overview
• 25.2. Canada Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Foods For Orphan Diseases Market

• 26.1. South America Medical Foods For Orphan Diseases Market Overview
• 26.2. South America Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Foods For Orphan Diseases Market

• 27.1. Brazil Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Foods For Orphan Diseases Market

• 28.1. Middle East Medical Foods For Orphan Diseases Market Overview
• 28.2. Middle East Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Foods For Orphan Diseases Market

• 29.1. Africa Medical Foods For Orphan Diseases Market Overview
• 29.2. Africa Medical Foods For Orphan Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Foods For Orphan Diseases Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Foods For Orphan Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Foods For Orphan Diseases Market Competitive Landscape And Company Profiles

• 30.1. Medical Foods For Orphan Diseases Market Competitive Landscape
• 30.2. Medical Foods For Orphan Diseases Market Company Profiles
  • 30.2.1. Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Ajinomoto Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Meiji Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Foods For Orphan Diseases Market Other Major And Innovative Companies

• 31.1. Fresenius Kabi AG
• 31.2. BioMarin Pharmaceutical Inc.
• 31.3. Halyard Health
• 31.4. Alfasigma spA
• 31.5. Ultragenyx Pharmaceutical Inc.
• 31.6. Immedica Group AB
• 31.7. Vitaflo International Ltd.
• 31.8. Leadiant Biosciences Inc.
• 31.9. Alcresta Therapeutics Inc.
• 31.10. Cambrooke Therapeutics Inc.
• 31.11. Primus Pharmaceuticals Inc.
• 31.12. CANbridge Pharmaceuticals Inc.
• 31.13. Cerecin Inc.
• 31.14. AMNIOX Medical Inc.
• 31.15. Targeted Medical Pharma Inc.

32. Global Medical Foods For Orphan Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Foods For Orphan Diseases Market

34. Recent Developments In The Medical Foods For Orphan Diseases Market

35. Medical Foods For Orphan Diseases Market High Potential Countries, Segments and Strategies

• 35.1 Medical Foods For Orphan Diseases Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Foods For Orphan Diseases Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Foods For Orphan Diseases Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer